Edward M Barksdale

Title: The Innovations of Edward M Barksdale

Introduction

Edward M Barksdale is a notable inventor based in Cincinnati, OH. He has made significant contributions to the field of medical science, particularly in the treatment of tumors. His innovative approach utilizes the glycoprotein Mullerian Inhibiting Substance (MIS) for therapeutic applications.

Latest Patents

Barksdale holds a patent for the "Use of Mullerian Inhibiting Substance for Treating Certain Tumors." This patent focuses on the treatment of specific tumors using an effective amount of MIS. It also discusses the C-terminal fragment of MIS and its potential in tumor treatment. The application includes DNA sequences encoding this fragment, vectors containing the DNA sequence, and transformed host cells capable of producing the C-terminal fragment. Furthermore, it explores gene therapy treatments aimed at inhibiting the growth of certain tumors.

Career Highlights

Edward M Barksdale is associated with The General Hospital Corporation, where he has been able to apply his research and innovations in a clinical setting. His work has the potential to impact cancer treatment significantly.

Collaborations

Barksdale has collaborated with notable colleagues such as Richard C Ragin and David T MacLaughlin. Their combined expertise has likely contributed to the advancements in his research and patent applications.

Conclusion

Edward M Barksdale's work exemplifies the intersection of innovation and medical science. His contributions to tumor treatment through the use of MIS highlight the importance of research in developing effective therapies.